Health & Healthcare

For U.S. healthcare systems, clinical and financial stability can be achieved when we look beyond treatment options for individual disease states and instead take a more holistic approach that also addresses the pathological mechanisms that extend across multiple disease states.

Cleft lips and cleft palates affect far more than a child’s appearance. They can impact feeding, nutrition, speech, hearing, dental development, emotional wellbeing, and long-term healthcare from the moment a child is born.

In 2025, DaVita expanded its work with the YMCA to support chronic kidney disease (CKD) education and prevention.

Stayfree® and Carefree® are helping expand puberty and menstrual health education in Argentina through a hybrid program that combines classroom resources, educator tools, product access, and interactive learning experiences.

Aflac, a pioneer and leader in cancer insurance for seven decades, today announced the launch of Fit Checks, an innovative new awareness campaign developed with fashion designer Rachel Zoe

The Melanoma Research Foundation (MRF), the largest independent organization devoted to melanoma eradication, today announced a joint one-day consensus meeting sponsored by Neutrogena® to coincide with the start of UV Safety and Awareness Month.

Firefighters accept extraordinary risk in the line of duty. But for Brian Ryll, president of the Professional Fire Fighters of New Hampshire, the most insidious threat is the one that often goes unseen: cancer.

Direct Relief is sending over a quarter million N95 respirators donated by 3M to help protect health workers on the front lines of the Ebola outbreak, responding to widespread PPE shortages reported across eastern Democratic Republic of Congo.

Have chronic congestion? “Stop consuming dairy.” Unrelenting belly problems? “Mmmm, could be cow’s milk.” Have you let this thinking guide your decision to avoid dairy? If so, you may lose out on essential macro and micronutrients.

When it comes to cancer, progress is often measured not only by new treatments, but by how early the disease can be found. For Ryan Schoenfeld, Ph.D., CEO of The Mark Foundation for Cancer Research, that distinction has become a defining focus